Habiendo aspirado a America Dry, los gigantes tecnológicos buscan nuevos mercados más allá del alcance de las leyes antimonopolio de EE. UU.

Un impulso agresivo para consolidarse en todas las empresas del sector, junto con la dependencia cada vez mayor del mundo de las plataformas y herramientas digitales, está conduciendo rápidamente a una crisis de soberanía.

Raul Diego
Por Raul Diego
Zuckerberg Modi

The American consumer market for big tech gadgets appears to have reached the point of saturation as the novelty of mobile devices and laptops plateau and the persistent lockdown sees savings dwindle and discretionary spending disappear. Apple, which has enjoyed reigning over the smartphone market for more than a decade, has been forced to drop its

Lea el artículo completo

COVID-19 está descubriendo cómo Big Ag está llevando a los pequeños agricultores de Estados Unidos al matadero

A medida que se abre la puerta para una mayor consolidación en todas las industrias, los intereses alimentarios transnacionales más amplios y arraigados sienten el calor de los agricultores y ganaderos estadounidenses para frenar sus sueños monopolísticos.

Raul Diego
Por Raul Diego
Tyson Foods Feature photo

There is a bottleneck in the nation's food supply chain. Specifically in the meatpacking operations of the country's "big four": Tyson Foods, National Beef, Cargill, and Brazilian giant JBS - the world's largest processor of beef and pork products. The logjam has been exacerbated by a slew of coronavirus outbreaks in Iowa meatpacking plants and

Lea el artículo completo

Trump’s Meetings With CEOs Seeking Mergers Is Troubling Observers

By meeting with the CEOs of Monsanto and Bayer as well as the head of AT&T, which is trying to merge with Time Warner, Trump has violated decades of White House practice by injecting himself directly into mergers awaiting Justice Department review.

Justin Elliot
Jesse Eisinger
Por Justin Elliot
Y Jesse Eisinger
President Donald Trump speaks during his meeting with automobile leaders in the Roosevelt Room of the White House in Washington, Tuesday, Jan. 24, 2017. (AP/Pablo Martinez Monsivais)

(ANALYSIS) --- When the CEOs of Monsanto and Bayer met now-President Donald Trump earlier this month, eager for a nod of assent for their controversial merger into an agrochemical and seed giant, they promised jobs and investment. Sure enough, a week later, the companies and a Trump spokesman announced that the combined company would create

Lea el artículo completo

Nestle Spent $11M Lobbying Congress To Control Water, Cocoa & Trade Since 2013

Nestlé is also a funder of the American Legislative Exchange Council, the controversial corporate think tank which produces model legislation that’s later introduced by the state legislators it sponsors.

Kit O'Connell
Por Kit O'Connell
Paul Bulcke, CEO of Nestle, attends a press conference. (AP Photo/Saurabh Das)

AUSTIN, Texas --- Nestlé’s political influence in the United States is backed by a generous war chest which funds the often controversial company’s efforts to lobby against the types of trade, labor, and environmental regulations which might impede its profits. The Swiss multinational has been accused of using slave labor in the seafood and

Lea el artículo completo

Bayer Buys Monsanto But AntiTrust Laws Could Still Kill The Deal

Bayer, who made it rich selling heroin to children and financing Nazi concentration camps, is set to pay over $128 a share to buy the world’s most notorious GM seed company.

Whitney Webb
Por Whitney Webb
A protester wearing a protective suit and mask holds up a sign toward passing cars that reads in Portuguese "A better world according to Monsanto is a world with more cancer" in Sao Paulo, Brazil, Saturday, May 25, 2013. (AP/Nelson Antoine)

German pharmaceutical and agrochemical company Bayer has finally succeeded in its attempts to buy US GM seed company Monsanto. The merger will create a company that commands more than 25% of the world’s agricultural market for seeds and pesticides. Bayer first attempted to buy Monsanto for $62 billion this past May but was unsuccessful as Monsanto

Lea el artículo completo

Supreme Court: Big Pharma’s Paying To Delay Generic Drugs Can Be Challenged In Courts

Drug companies had hoped the court to would immunize their agreements, which keep cheaper forms of medicine off the market.

Associated Press
Por Associated Press
Prescription drugs line a cabinet in this March 25, 2011 photo. (Photo by Eric Hunsaker via Flikr)

WASHINGTON — Deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal and therefore can be challenged in court, the Supreme Court said Monday. The justices voted 5-3 to allow the government to inspect and challenge what it

Lea el artículo completo